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Introduction
The saprophytic fungus Aspergillus fumigatus is a serious health 
hazard in hospitals (Latge, 1999, 2001). A. fumigatus is respon-
sible for >90% of invasive aspergilloses (IA), with mostly fatal 
outcomes in immunocompromised patients suffering from 
AIDS, tuberculosis, cancer, or bone marrow/organ transplants 
(Latge, 1999; Bauters et al., 2005). The true incidence of 
A.   fumigatus infections is underestimated because of the inherent 
diffi  culty of positive diagnosis (Latge, 1999).
Second-generation anti-fungals, such as amphotericin B 
lipid forms, echinocandins, and azoles, have only shown   modest 
improvements in effi  cacy and at lower toxicity. Thus, anti–
A.   fumigatus therapy remains inadequate and, as a consequence, 
high morbidity and mortality from IA prevails  (Latge, 1999; 
Bauters et al., 2005). One reason for this is our poor under  standing 
of the pathobiology of A. fumigatus. A multitude of putative 
A. fumigatus virulence factors, such as extracellular metallopro-
tease, serine protease, aspartic protease, catalase, phospholipases, 
  haemo  lysin, and the cytotoxin ASPF1 have been implicated in IA, 
but none has yet been shown to be involved in the pathogenesis of 
A. fumigatus in experimentally induced infections (Latge, 2001).
Gliotoxin (GT), an abundant mycotoxin produced by 
A. fumigatus and other fungi, such as Candida albicans, belongs 
to the epipolythiodioxopiperazine class of secondary metabo-
lites (Taylor, 1971) and is characterized by a reactive disulfi  de 
bridge across the piperazine ring (Mullbacher et al., 1986). 
GT has been proposed to constitute a virulence factor in IA 
because of its immunosuppressive properties (Eichner and 
Mullbacher, 1984; Mullbacher and Eichner, 1984). GT has 
been shown in vitro to inhibit multiple processes associated 
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A
spergillus fumigatus infections cause high levels 
of morbidity and mortality in immunocompro-
mised patients. Gliotoxin (GT), a secondary meta-
bolite, is cytotoxic for mammalian cells, but the molecular 
basis and biological relevance of this toxicity remain 
speculative. We show that GT induces apoptotic cell death 
by activating the proapoptotic Bcl-2 family member Bak, 
but not Bax, to elicit the generation of reactive oxygen 
species, the mitochondrial release of apoptogenic factors, 
and caspase-3 activation. Activation of Bak by GT is 
  direct, as GT triggers in vitro a dose-dependent release 
of cytochrome c from puriﬁ   ed mitochondria isolated 
from wild-type and Bax- but not Bak-deﬁ  cient cells. Resis-
tance to A. fumigatus of mice lacking Bak compared to 
wild-type mice demonstrates the in vivo relevance of this 
GT-induced apoptotic pathway involving Bak and  suggests 
a correlation between GT production and virulence. The 
elucidation of the molecular basis opens new strategies 
for the development of therapeutic regimens to   combat 
A. fumigatus and related fungal infections.
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with   activation, differentiation, and/or effector functions of 
immune cells (  Mullbacher et al., 1987; Waring et al., 1988a; 
Gardiner et al., 2005). This includes activation of NF-κB (Pahl 
et al., 1996), neutrophil and macrophage oxidative killing 
(Mullbacher et al., 1985; Murayama et al., 1996;   Tsunawaki 
et al., 2004), polymorphonuclear neutrophils chemotaxis 
(Shah et al., 1998), polymorphonuclear neutrophils and macro-
phage phagocytosis (Mullbacher et al., 1985;   Eichner et al., 
1986; Murayama et al., 1996; Shah et al., 1998), activation 
of cytolytic T cells (  Mullbacher and   Eichner, 1984; Waring 
et al., 1988a), and IFNγ production by CD4
+ lymphocytes 
(  Wichmann et al., 2002). Most important, GT was found to in-
duce mammalian cell apoptosis (Waring et al., 1988b;   Sutton 
et al., 1994) accompanied by the production of reactive oxy-
gen species (ROS) and mitochondrial membrane disruption 
(Eichner et al., 1988; Zhou et al., 2000; Suen et al., 2001; 
Kweon et al., 2003). The proposition that GT is a virulence 
factor is supported by more recent fi  ndings demonstrating 
that GT is expressed in vivo during experimental and human 
aspergillosis (Lewis et al., 2005) and that the decreased lev-
els of pulmonary GT observed with an A.   fumigatus mutant 
defective in LaeA, a global regulator of secondary metabo-
lism, is associated with impaired virulence (Bok et al., 2005; 
unpublished data). However, it should be noted that LaeA 
regulates expression of a cassette of genes,   including GT 
and other secondary metabolites. Thus, the virulence of the 
wild-type (wt) strain of A. fumigatus is not necessarily linked 
to GT alone.
Defi   nitive evidence on the molecular basis of GT-
  mediated apoptosis and its relevance in the parasitized ver-
tebrate host is still lacking. Many diverse stimuli, including 
irradiation, toxic drugs, and pathogens, transduce apoptotic 
signals to mammalian cells, resulting in the disruption of mi-
tochondrial membranes (Kroemer and Reed, 2000; Dockrell, 
2001; Green and Kroemer, 2004) and the subsequent release 
of apoptotic factors, such as cytochrome c and apoptosis-
inducing factor (AIF; Liu et al., 1996; Susin et al., 1999; 
Pardo et al., 2001). Complex formation of cytochrome c with 
Apaf-1 and caspase-9 leads to further induction of effector 
caspases, i.e., caspase-3 and -7 (Li et al., 1997). Permeabiliz-
ing the   mitochondrial   membranes by diverse stimuli strictly 
depends on the proapoptotic Bcl-2 family members Bak and 
Bax (Marzo et al., 1998;   Shimizu et al., 1999). This is in-
dicated by the fact that defi  ciency in Bax and Bak renders 
cells resistant to numerous apoptotic stimuli (Wei et al., 2000, 
2001). Although how Bax and Bak are regulated is still de-
bated, it has become clear that they are somehow activated 
by BH3-only proteins, which trigger their conformational 
change, oligomerization, and pore forming activity (Letai 
et al., 2002; Willis et al., 2005). Among BH3-only molecules, 
Bid and Bim may directly activate Bax and Bak by a hit-and-
run mechanism (Kuwana et al., 2005), whereas other mem-
bers of this family seem to act by antagonizing the survival
activity of antiapoptotic proteins, i.e., Bcl-2, Bcl-xL, and Mcl-1 
(Huang and   Strasser, 2000; Chen et al., 2005;   Willis et al., 
2005).   However, it has not yet been studied by which media-
tors/effectors GT   induces mitochondrial membrane disrup-
tion and apoptosis.
We show now for the fi  rst time that Bak, which consti-
tutively resides on mitochondria (Griffi  ths et al., 1999), is the 
  primary intracellular target in GT-mediated and ROS-  facilitated 
apoptosis in vitro and that in a corticosteroid-based IA model, 
a knockout mouse strain lacking Bak is more resistant to 
A.  fumigatus than wt mice.
Results
GT induces apoptosis in mouse embryonic 
ﬁ  broblast (MEF) cells
As GT may induce apoptosis and necrosis in mammalian cells, 
depending on the concentration of GT and the target cell used 
(Braithwaite et al., 1987; Hurne et al., 2002; Kweon et al., 2003; 
Orr et al., 2004), we fi  rst established optimal conditions that 
allowed us to readily monitor proapoptotic processes in MEFs. 
As shown in Fig. 1 A, 1 μM GT induced nuclear fragmenta-
tion in the majority of wt MEFs. Furthermore,  50% of these 
cells were apoptotic, i.e., had phosphatidylserine (PS) exposed 
  (annexin V staining) without plasma membrane disruption, 
whereas the rest of the cells already showed secondary necrosis 
(loss of membrane integrity as shown by propidium iodide [PI] 
staining; Fig. 1 B; Pardo et al., 2004). Thus, 1 μM GT was used 
in all subsequent experiments.
Figure 1.  GT induces apoptosis in MEFs. 
wt MEFs were incubated with or without 1 μM 
GT for 4 h and stained with Hoechst 33342 (A) 
or annexin V–FITC plus PI (B), and ﬂ  uorescence 
images were taken as described in Materials 
and methods. Bars: (A) 25 μm; (B) 40 μm.BAK AS A TARGET OF FUNGAL VIRULENCE AND CYTOTOXICITY • PARDO ET AL. 511
GT-induced apoptosis depends on Bak 
but not Bax and/or Bid
We next compared GT-induced PS exposure and PI staining be-
tween wt and knockout (−/−) MEFs. In addition, we studied the 
impact of GT on the ∆ψm and the production of ROS in these 
cells. As shown in Fig. 2 A, GT signifi  cantly increased the num-
ber of annexin V/PI–positive cells in wt, Bax
−/−, and Bid
−/− 
MEFs as compared with mock-treated cells, whereas Bak
−/− and 
Bak
−/− × Bax
−/− MEFs did not. Similarly, GT treatment led to 
a signifi  cant reduction in the mitochondrial membrane potential 
(∆ψm) and a parallel increase in ROS production in wt, Bax
−/−, 
and Bid
−/−, but not in Bak
−/− and Bak
−/− × Bax
−/− MEFs (Fig. 
2 B). It is our experience that there is considerable variation in 
the numbers of cells induced to express the respective proapop-
totic markers from experiment to experiment. However, the dif-
ferentials between experimental and control groups in individual 
experiments were always highly signifi  cant. This suggests that in 
MEFs, Bak, but not Bax, is critical for GT-induced loss of plasma 
membrane integrity and the ∆ψm. Moreover, Bid, which is known 
to activate Bak and Bax during apoptosis (Wei et al., 2001; Letai 
et al., 2002; Kuwana et al., 2005), seems to be dispensable for 
these processes. In support of a key role of Bak in GT-mediated 
cell death, we found that trypan blue exclusion was signifi  cantly 
reduced only in Bak
−/− and Bak
−/− × Bax
−/−, but not in wt or 
Bax
−/− MEFs (Fig. 2 D). In contrast to GT-induced apoptosis, 
the apoptosis-inducing drug staurosporine induced reduction in 
the ∆ψm and a parallel increase in ROS, which was only pre-
vented in the absence of both Bak and Bax, as already described 
(Fig. 2 C; Wei et al., 2001).
GT induces conformational change of Bak 
but not Bax, independent of Bid, caspase 
activation, or ROS generation
Upon their activation, Bak and Bax undergo conformational 
changes, leading to the exposure of their N-terminal domains   
(Hsu et al., 1997; Griffi  ths et al., 1999; Nechushtan et al., 1999). 
To test whether this process also occurs during GT treatment, 
wt and Bak
−/− × Bax
−/− MEFs were incubated with GT and 
subsequently analyzed by FACS with conformation-specifi  c 
antibodies against the N termini of Bak or Bax. As shown in 
Fig. 3 A, GT was able to readily induce N-terminal epitope expo-
sure in Bak but not in Bax. As expected, no (Bax) or only margi-
nal staining (Bak) was seen with these antibodies in GT-activated 
Bak
−/− × Bax
−/− MEFs. There was no inherent failure of Bax 
to undergo an N-terminal conformational change in MEFs, as 
their treatment with staurosporine led to the expected N-terminal 
opening of Bax (Fig. 3 B; Griffi  ths et al., 1999; Wei et al., 2001).
To determine the order of events during Bak activation, 
ROS production, and caspase activation, we incubated GT-
treated MEFs with the antioxidants N-acetylcysteine (NAC) or 
the manganese porphyrin Mn(III) tetrakis(4-benzoic acid) por-
phyrin chloride (MnTBAP; Faulkner et al., 1994; Day et al., 
1997) or the pan-caspase inhibitor ZVAD-fmk (Pardo et al., 
2004). NAC and MnTBAP were both effective as antioxidants, 
as they signifi  cantly reduced GT-induced ROS production in 
MEFs (Fig. 3 C). Moreover, ZVAD-fmk blocked apoptosis 
  induced by the anti(α)-Fas mAb Jo-2 in MBL-2–Fas cells 
(Fig. 3 C). GT-induced N-terminal opening of Bak was unaf-
fected by any of the three inhibitors (Fig. 3 D), indicating that 
Figure 2. GT-induced apoptosis is Bak 
  dependent.  (A and B) wt, Bak
−/−, Bax
−/−, 
Bak
−/− × Bax
−/−, and Bid
−/− MEFs were incu-
bated with or without 1 μM GT for 4 h and ana-
lyzed by FACS for PS exposure (annexin V–FITC) 
and PI uptake (A) or ∆ψm loss (DiOC6[3]) and 
ROS generation (2-HE; B). (C) wt, Bak
−/−, 
Bax
−/−, and Bak
−/− × Bax
−/− MEFs were incu-
bated with or without 1 μM staurosporine (STP) 
for 12 h and analyzed by FACS, as in B. The 
same cells were incubated with increasing 
amounts of GT for 4 h to determine the percent-
age of cell death (trypan blue exclusion) by 
  microscopic inspection (D). Data shown in A, B, 
and D are representative of at least four inde-
pendent experiments with similar outcome.JCB • VOLUME 174 • NUMBER 4 • 2006  512
ROS production and caspase activation occur downstream of 
Bak activation. Furthermore, as similar activation of Bak was 
seen in GT-treated wt and Bid
−/− MEFs, GT-mediated confor-
mational change of Bak is also independent of Bid (Fig. 3 E).
GT-induced mitochondrial and membrane 
damage depends on ROS production
Although the association of ROS generation with GT- or CTL-
mediated apoptosis is well documented (Kweon et al., 2003; Pardo 
et al., 2004), the contribution of ROS to cell death is still contro-
versial (Chandra et al., 2000; Danial and Korsmeyer, 2004). We 
therefore tested the effect of NAC and MnTBAP on GT-  induced 
plasma and mitochondrial membrane integrity and cell death. 
As shown in Fig. 4 A, the addition of NAC to wt MEFs 
at a concentration known to inhibit ROS generation (Fig. 3 C; 
Pardo et al., 2004) abrogated GT-induced PS exposure and plasma 
membrane permeability, as well as the reduction of the mitochon-
drial ∆ψm. Moreover, at 1 μM GT, NAC totally inhibited cell 
Figure 3.  GT induces conformational change of Bak. (A and B) GT   induces 
conformational change of Bak, but not Bax, in MEFs. wt and Bak
−/− × 
Bax
−/− MEFs were incubated for 4 h without (black) or with (red) either 
1 μM GT (A) or 1 and 5 μM staurosporine (B) and analyzed by FACS for 
conformational changes of Bak and Bax using mAbs speciﬁ  c for the func-
tionally active N-terminal region in each protein. Numbers given are the 
percentages of cells positive for active Bak or Bax (indicated by the hori-
zontal bars). (C–E) GT-induced conformational change of Bak is indepen-
dent of caspase activation, ROS generation, and the presence of Bid. 
(C) The ROS scavengers NAC and MnTBAP were tested for their efﬁ  ciency 
in inhibiting ROS production by FACS analysis (2-HE) of wt MEFs treated 
with 1 μM GT for 4 h. To test for the caspase-inhibiting potency of ZVAD-
fmk, MBL-2–Fas cells were treated with 1 μg/ml of the α-Fas antibody Jo-2 
in the absence and presence of 100 μM ZVAD-fmk, and cell death was 
monitored by trypan blue exclusion. (D) wt MEFs were incubated with (red) 
or without (black) 1 μM GT for 4 h in the presence or absence of 100 μM 
ZVAD-fmk (green), 15 mM NAC, or 200 μM MnTBAP. The cells were ana-
lyzed by FACS for conformational changes of Bak as under A. (E) GT-
  induced conformational change of Bak is independent of Bid. wt and 
Bid
−/− MEFs were treated with GT and FACS analyzed for conformational 
changes of Bak as in A. Numbers given are the percentages of cells 
  positive for active Bak (indicated by the horizontal bars). Data shown 
are representative of at least three independent experiments with 
similar outcome.
Figure 4.  GT-induced mitochondrial membrane perturbation and apopto-
sis are dependent on ROS generation, whereas only the latter partially 
  depends on caspases. (A) wt MEFs were incubated with or without 1 μM 
GT for 4 h in the presence or absence of 100 μM of the pan-caspase in-
hibitor ZVAD-fmk (green) or 15 mM of the ROS scavenger NAC and ana-
lyzed by FACS for PS exposure (annexin V–FITC)/PI uptake and ∆ψm loss 
(DiOC6[3])/ROS generation (2-HE). (B) wt MEFs were incubated with in-
creasing amounts of GT for 4 h in the presence or absence of ZVAD-fmk or 
NAC, and the percentage of cell death (trypan blue exclusion) was deter-
mined by microscopic inspection. (C) wt, Bak
−/−, Bax
−/−, and Bak
−/− × 
Bax
−/− MEFs were incubated with (red) or without (black) 1 μM GT for 
4 h and analyzed by FACS for the activation of caspase-3, using an 
α–  caspase-3 mAb (FITC labeled) against the active form of the enzyme. 
A representative FACS analysis represented as histogram (C, bottom) and 
a graph showing the mean ± SEM from four independent experiments 
(right) is shown. ns, P = 0.1730; **, P = 0.0002; ***, P = 0,0012. 
  Analyzed by two-tailed unimpaired t test comparing wt versus knockouts. 
(D) wt, Bak
−/−, Bax
−/−, and Bak
−/− × Bax
−/− MEFs were incubated with 
(green) or without (black) 1 μM staurosporine for 4 h and analyzed by 
FACS for the activation of caspase-3, as in C.BAK AS A TARGET OF FUNGAL VIRULENCE AND CYTOTOXICITY • PARDO ET AL. 513
death (according to the absence of trypan blue staining; Fig. 4 B). 
Similar results were obtained with MnTBAP, indicating that the 
effect of NAC was due to its antioxidant properties (unpublished 
data). These data reveal that ROS generation is crucial for GT-
  induced changes of plasma membrane permeability, the mito-
chondrial ∆ψm, and cell death.
GT-induced caspase-3 activation depends 
on Bak activation
To determine the role of caspases in the GT-induced reduc-
tion of the mitochondrial ∆ψm and apoptosis, we tested 
whether GT could induce cell death and changes in mito-
chondrial ∆ψm in the presence of the broad spectrum caspase 
inhibitor ZVAD-fmk. 100 μM ZVAD-fmk did not prevent 
loss of the mitochondrial ∆ψm in GT-treated cells, indicating 
that caspase activation was not needed for this event. How-
ever, ZVAD-fmk partially reduced GT-induced annexin V/PI 
staining (Fig. 4 A) but did not affect cell death (Fig. 4 B). 
These data also exclude a possible role of death receptor–
mediated cell death, which is completely blocked by caspase 
inhibitors (Fig. 3 C; Longthorne and Williams, 1997). To test 
whether the major downstream effector caspase, caspase-3, 
was involved in these processes, and whether activation of 
this caspase was dependent on Bak, we performed a FACS 
analysis of wt and −/− MEFs using an α–caspase-3 mAb 
specifi  c for the processed active form of caspase-3. As shown 
in Fig. 4 C, caspase-3 was signifi  cantly activated in GT-
treated wt and Bax
−/− but not in Bak
−/− and Bak
−/− × Bax
−/− 
MEFs. In contrast, staurosporine induced caspase-3 activa-
tion in Bak
−/− and Bax
−/− but not in Bak
−/− × Bax
−/− MEFs 
(Fig. 4 D), again showing that both Bak and Bax can undergo 
conformational activation upon appropriate stimulus (Wei 
et al., 2001).
GT-induced release of cytochrome c 
depends on Bak activation 
and ROS production
The activation of Bak and the subsequent production of ROS 
and the reduction of mitochondrial ∆ψm in response to GT indi-
cate increased mitochondrial membrane permeability, leading 
to the release of apoptogenic factors such as cytochrome c and 
AIF. Although cytochrome c activates caspase-3 via the apop-
tosome (Li et al., 1997), AIF translocates to the nucleus and 
contributes to DNA fragmentation in a caspase-  independent 
manner (Susin et al., 1999; Pardo et al., 2001). The release of 
both cytochrome c and AIF from mitochondria is absolutely 
dependent on activation of Bax, Bak, or both (Lindsten et al., 
2000; Wei et al., 2001). To test whether GT-induced cyto-
chrome c release selectively required Bak, wt, Bak
−/−, Bax
−/−, 
or Bak
−/− × Bax
−/− MEFs were incubated with GT and mito-
chondrial cytochrome c was quantitatively measured by FACS 
analysis (Fig. 5 A). In addition, AIF release was monitored by 
α-AIF immunofl  uorescence (Fig. 6 A). As shown in Fig. 5 A, 
mitochondrial cytochrome c was reduced in GT-treated wt and 
Bax
−/− MEFs but retained in Bak
−/− or Bak
−/− × Bax
−/− MEFs.
In addition, a high portion of GT-treated wt and Bax
−/− 
MEFs displayed cytosolic localization and nuclear translo-
cation of AIF, whereas Bak
−/− and Bak
−/− × Bax
−/− MEFs 
retained most of the AIF in the mitochondria (Fig. 6 A). 
These data confi  rm that GT induced mitochondrial mem-
brane permeability; i.e., cytochrome c and AIF release occurs 
by a process selectively involving Bak. To test whether GT 
could directly act on mitochondrial Bak without the require-
ment of any cytosolic factors, such as, for example, a particu-
lar BH3-only protein, we compared GT-  induced cytochrome c
release on isolated mitochondria from wt MEFs with those 
of knockout MEFs and factor-dependent myeloids (FDMs). 
Figure 5.  GT-induced cytochrome c release 
from mitochondria is dependent on Bak and the 
ROS generation. (A) wt, Bak
−/−, Bax
−/−, and 
Bak
−/− × Bax
−/− MEFs were incubated with 
(red) or without (black) 1 μM GT for 4 h and 
analyzed by FACS for mitochondrial release of 
  cytochrome c using a α–cytochrome c mAb fol-
lowed by a FITC-labeled secondary antibody. 
Numbers depicted are the percentages of cells 
negative for cytochrome c (indicated by hori-
zontal bars). (B) Mitochondria isolated from wt, 
Bax
−/−, Bak
−/−, and Bak
−/− × Bax
−/− FDMs 
(left) or MEFs (right) were treated with 10, 20, 
or 50 μM of GT or 40 nM of tBid for 4 h in vitro. 
After centrifugation, cytochrome c was measured 
in mitochondria and the supernatant by α–
  cytochrome c Western blotting (i). In parallel, the 
presence of Bak and Bax was analyzed in MEF 
wt, Bax
−/−, and Bak
−/− by simultaneous α-Bax 
and α-Bak immunoblotting of the mitochondrial 
preparations. As control, an antibody against 
the α subunit of the H
+-ATPase was used (ii). 
(C) wt MEF cells were incubated with (red) or 
without (black) 1 μM GT for 4 h in the presence 
or absence of 100 μM ZVAD-fmk (green) or 
15 mM NAC (blue) and analyzed by FACS for 
mitochondrial release of cytochrome c as in A. 
Data shown are representatives of at least three 
independent experiments with similar outcome.JCB • VOLUME 174 • NUMBER 4 • 2006  514
As shown in Fig. 5 B i, 10–50 μM GT caused cytochrome c 
release from isolated wt mitochondria in a dose-dependent 
manner. The requirement for much higher concentrations of 
GT to induce cytochrome c release in isolated mitochondria 
as compared with intact cells is in line with a previous study in 
which GT-mediated calcium release was analyzed (Schweizer 
and   Richter, 1994). In fact, it is known that levels of GT de-
termined intracellularly do exceed those originally applied in 
solution by up to 1,500-fold (Waring et al., 1994; Bernardo 
et al., 2003). The release of cytochrome c was as effi  cient as 
that induced by recombinant tBid, a known inducer of mito-
chondrial membrane permeability via Bak/Bax (Wei et al., 
2000, 2001) and signifi  cantly greater than the background re-
lease of cytochrome c observed in mock-treated mitochondrial 
preparations. Strikingly, although mitochondria from Bax
−/− 
showed similar GT-induced cytochrome c release as wt mito-
chondria, mitochondria from Bak
−/− or Bak
−/− × Bax
−/− did 
not, irrespective of whether they were derived from MEFs or 
FDMs. This suggests that GT does not need cytosolic factors 
such as tBid or caspases to elicit cytochrome c release but may 
act directly on mitochondrial Bak or some as-yet-unknown 
  mitochondrial protein that activates Bak with a potency similar 
to tBid. We excluded the possibility that the resistance of GT-
facilitated cytochrome c released could be due to the absence 
of Bax on mitochondria, as appreciable amounts of this protein 
were detected on isolated, washed mitochondria from both wt 
and Bak
−/− FDMs (Fig. 5 B ii). Moreover, tBid was capable 
of inducing cytochrome c release from mitochondria isolated 
from both Bak
−/− FDMs and MEFs. This would not have been 
possible if they had no Bax.
Consistent with a direct action of GT on mitochondrial 
membrane permeability, GT-induced cytochrome c and AIF 
release was not blocked by ZVAD in wt MEFs (Fig. 5 C and 
Fig. 6 B). Most important, however, both cytochrome c and AIF 
release from mitochondria was greatly diminished by NAC 
(Fig. 5 C and Fig. 6 B). This suggests that GT-induced ROS 
production is crucial for effective release of apoptogenic factors 
from mitochondria but does not exclude the possibility that 
NAC has some other mitochondrial membrane stabilizing activity.
Bak-deﬁ  cient mice are resistant to IA
To determine whether the selective activation of Bak during 
GT-mediated cell death as seen in our in vitro analysis is of 
  biological relevance and pathophysiological signifi  cance, we 
monitored the mortality of immunosuppressed (hydrocortisone-
treated) wt (C57BL/6) and Bak ko (Bak
−/−) mice subsequently 
infected with a GT-producing A. fumigatus strain. The presence 
of GT synthesis by this fungal strain was verifi  ed by HPLC 
analysis of culture SN (Fig. 7 B). Fig. 7 A shows that 5 out of 
6 wt mice died within 2 wk after intranasal infection, and only 
1 out of 6 Bak
−/− mice succumbed over the same time period 
(P < 0.015). These in vivo data correlate with our in vitro fi  nd-
ings and show for the fi  rst time that Bak is a host susceptibility 
factor for A. fumigatus virulence in mice, probably because of 
its direct activation by GT.
Discussion
Although GT has long been proposed to constitute a viru-
lence factor in IA (Eichner and Mullbacher, 1984; Mullbacher 
Figure 6.  GT-induced AIF translocation to the 
nucleus is dependent on Bak and the gen-
eration of ROS. (A) wt, Bak
−/−, Bax
−/−, and 
Bak
−/− × Bax
−/− MEF cells were incubated 
with or without 1 μM GT for 4 h and analyzed 
by confocal microscopy for nuclear transloca-
tion of AIF using a speciﬁ  c α-AIF rabbit anti-
body. Numbers depicted are the percentages 
of cells with nuclear AIF. (B) Alternatively, wt 
MEFs were incubated with or without 1 μM 
of GT for 4 h in the presence or absence of 
100 μM ZVAD-fmk or 15 mM NAC and ana-
lyzed for nuclear translocation of AIF as de-
scribed above. Data are representative of two 
independent experiments. Bars, 10 μm.BAK AS A TARGET OF FUNGAL VIRULENCE AND CYTOTOXICITY • PARDO ET AL. 515
and Eichner, 1984), most probably by suppressing immune 
  responses via induction of mammalian cell apoptosis (Waring 
et al., 1988b; Sutton et al., 1994), the molecular mechanisms 
underlying the putative in vitro and in vivo processes have not 
been   elucidated. Here, we present evidence that Bak, but not 
Bax, is a key host factor in GT-mediated cell death in vitro. We 
used MEFs and FDMs defi  cient in the Bcl-2 family members 
Bak and/or Bax or their activator Bid (Wei et al., 2000) and iso-
lated mitochondria from these cells to show that GT-  mediated 
activation of Bak occurs independently of Bid or other cyto-
solic   factors. Once activated, Bak triggers the generation of 
ROS, which is crucial for effective mitochondrial membrane 
pore formation, including the release of cytochrome c and AIF, 
and ultimate cell death. The additional fi  nding that the virulence 
of GT-producing A. fumigatus was signifi  cantly decreased in 
Bak
−/− over wt mice strongly implicates that GT is an important 
modulator in mammalian host defense and that Bak is a promi-
nent host susceptibility factor. The interrelation of GT and Bak 
in A. fumigatus pathology is also supported by the recent fi  nd-
ing that an A. fumigatus mutant lacking GT expresses a drasti-
cally reduced virulence (unpublished data).
At present, it is unclear how GT activates Bak. One 
mechanism by which GT may activate Bak is by breaking up 
inhibitory complexes between Bak and Bcl-2–like prosurvival 
factors (Sattler et al., 1997; Cuconati et al., 2003; Willis et al., 
2005; Ekert et al., 2006) or VDAC2 (Cheng et al., 2003) on the 
mitochondrial membrane. This could be by forming transient 
disulphide bonds between the reactive disulphide bond in GT 
and individual cysteine residues in Bak or its binding partners, 
leading to the release of active Bak. Three-dimensional struc-
tures of Bak–Bcl-2 or Bak–VDAC2 complexes have not yet 
been determined, so we do not know if any cysteine residues 
are involved in these interactions. Moreover, we do not have any 
experimental evidence that GT directly binds Bak, Bcl-2–like 
proteins, or VDAC2. However, our data obtained with isolated 
mitochondria favor an interpretation that GT-facilitated activa-
tion of Bak occurs by direct interaction with antiapoptotic Bcl-2 
family members or other mitochondrial membrane–associated 
  constituents. The former possibility is supported by the obser-
vation that protection against GT-mediated monocyte apoptosis 
by agonists of nerve growth factor receptors is associated with 
the up-regulation of Bcl-2 and Bcl-xL (la Sala et al., 2000).
The fi  nding that GT specifi  cally acts through Bak and not 
Bax is intriguing. Although both proteins are supposed to exert 
the same pore-forming activity on mitochondria (Kuwana et al., 
2005), they are activated differently. There is increasing evi-
dence for selective Bax- or Bak-specifi  c apoptosis, depending 
on the cell type and the apoptotic stimuli (Lindenboim et al., 
2005; Wendt et al., 2005). Thus, the activation mechanism of 
Bax and Bak may be distinct, although both ultimately oligo-
merize and form pores in the outer mitochondrial membrane. 
In this respect, GT may be unable to interact with Bax and/or to 
release any of its inhibitory components. Moreover, an interac-
tion of GT with Bcl-2 or Bcl-xL would not affect Bax because 
it is not sequestered by these proteins in healthy cells. This 
would explain why GT induces conformational activation of 
Bak but not of Bax.
The fi  ndings that the mitochondrial protein VDAC2 asso-
ciates with and inhibits Bak in healthy mitochondria (Cheng 
et al., 2003) and that in monocytes, Bak but not Bax is part of 
the VDAC channel (unpublished data) suggest VDAC2’s in-
volvement in GT-mediated cell death. VDAC2 is one of three 
mammalian isoforms of VDAC proteins (VDAC1, -2, and -3), 
which constitute the major pathway for metabolic exchange 
across the outer mitochondrial membrane (Sampson et al., 1997; 
Wu et al., 1999; Xu et al., 1999). Together with cyclophilin D 
and adenine nucleotide transporter (ANT), VDAC forms the 
  mitochondrial permeability transition pore (MPTP), involved 
in cell apoptosis and/or necrosis (Crompton, 1999; Zheng et al., 
2004). How the function of MPTP is regulated by members of 
the BH3 family is still highly controversial (Marzo et al., 1998; 
Shimizu et al., 1999; Vander Heiden et al., 1999). One could 
postulate that GT somehow modulates the VDAC complex, 
leading to the liberation of Bak, a subsequent increase of mito-
chondrial membrane permeability and hence a Bak-dependent 
cytochrome c release and cell death. The contribution of the 
MPTP in the latter process is further supported by the fi  ndings 
that GT-induced apoptosis of activated hepatic stellate cells is 
associated with a specifi  c thiol redox-dependent interaction with 
MPTP component ANT (Orr et al., 2004) and that cyclosporin A, 
an inhibitor of cyclophilin D and mitochondrial pore opening 
(Crompton et al., 1988), affected mitochondrial depolarization 
and ROS production (Kweon et al., 2003; unpublished data). 
Most notable, the data suggested that oxidative cross-linking of 
Figure 7.  Deletion of Bak results in resistance to mice of A. fumigatus. 
(A) Bak
−/− mice are resistant to A. fumigatus infection. Female wt C57BL6 
or Bak
−/− mice (6 mice per group) were immunosuppressed by subcutane-
ous injection of 2 mg of hydrocortisone in PBS/0.1% Tween-20 on days 
−4, −2, 0, 2, and 4 of infection. On day 0, recipients were inoculated in-
tranasally with 5 × 10
6 A. fumigatus B5233 in 20 μl of PBS or with 20 μl 
PBS alone (control), and morbidity and mortality was monitored during 
the time. Control mice survive without any symptoms of infection. Survival 
was signiﬁ  cantly different (P < 0.015), as analyzed by the Kaplan-Meier 
survival test. (B) A. fumigatus B5233 is able to produce GT. 10
7 A. fumigatus 
spores were inoculated in 100 ml of RPMI and grown for 48 h at 
37°C and 0.5% CO2, and the presence of GT in the SN (black) was 
assessed by HPLC, using a GT standard (inset) as described in Materials 
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two matrix-facing cysteine residues on the ANT (Cys
56 and 
Cys
159) plays a key role in regulating the MPTP (Halestrap et al., 
2002). However, more detailed studies, including MPTP inhibi-
tors such as bongkrekic acid or cyclosporins A, are required to 
dissect the role of the VDAC–ANT complex in GT-mediated 
and Bak-dependent cell death.
Our data further show that GT-induced production of ROS 
is mandatory for cell death. The sequence of events leading to 
ROS production by GT was revealed by analyzing the various 
proapoptotic processes in the presence of inhibitors for ROS 
and for caspases, including NAC, MnTBAP, and ZVAD-fmk, 
respectively (Fig. 8). Accordingly, activation of Bak precedes 
the generation of ROS, which then facilitate the release of cyto-
chrome c and AIF from mitochondria, leading to caspase activa-
tion as well as mitochondria- and caspase-independent events to 
mediate cell death. As to the source of ROS, it is possible that 
they are generated from a perturbance of mitochondrial respira-
tion that is due to Bak-mediated pore formation and/or activa-
tion of MPTP. Why ROS are, at least partially, required for 
cytochrome c release is unclear, although it has been shown 
that ROS generation is crucial for cytochrome c release under 
different apoptotic stimuli (Petrosillo et al., 2001; Orrenius and 
  Zhivotovsky, 2005; Santamaria et al., 2006).
The putative relevance of GT-mediated apoptosis for 
the parasitized vertebrate host was analyzed by comparing 
the course of A. fumigatus infection in wt and Bak
−/− mice. 
The signifi  cantly decreased virulence of the pathogen observed 
in Bak
−/− as compared with wt mice, as revealed by the differ-
ential kinetics of mortality, supports the following assumptions: 
GT is released during A. fumigatus infection, as suggested be-
fore (Eichner and Mullbacher, 1984; Lewis et al., 2005), and 
induces apoptosis in multiple target cells, most probably via 
Bak   activation. This process subsequently leads to an acceler-
ated colonization of target organs by breaching physical bar-
riers, such as lung and renal epithelial cells, and establishes 
an immunosuppressed state of the host. Although the present 
data do not formally proof a cause–effect relationship between 
GT, Bak activation, and A. fumigatus pathogenicity (virulence), 
the previous (Eichner and Mullbacher, 1984; Mullbacher and 
Eichner, 1984) and present assumption that GT is a virulence 
factor of A. fumigatus is   supported by a recent report (Bok 
et al., 2005) and our own unpublished data. These results have 
shown that low levels of pulmonary GT observed with an 
A. fumigatus mutant defective in LaeA, a global regulator of 
secondary   metabolism, is associated with impaired virulence of 
the pathogen.   Furthermore, by using a recently generated glip 
gene knockout mutant of A. fumigatus lacking GT, we found 
that this mutant is much less virulent in mice than the wt strain 
and that cell culture supernatants were unable to induce cell 
death (unpublished data).
Based on the sequence of intracellular events occurring 
during GT-induced apoptosis (Fig. 8), we conclude that GT is a 
critical virulence factor in A. fumigatus. This is supported by the 
fact that GT is one of the most abundant secondary metabolites 
produced by the fungus (Taylor, 1971) and that Bak
−/− mice are 
more resistant to infection by A. fumigatus. The distinct poten-
tial of GT to activate Bak, but not Bax, may be of relevance for 
the development of anti-IA drugs that selectively block cell 
death pathways via Bak and, at the same time, spare the residual 
proapoptotic proteins relevant for the control of the pathogen by 
the host’s immune system.
Materials and methods
Cell culture and reagents
SV40 transformed MEFs (Wei et al., 2001) and MBL-2–Fas cells were 
  cultured in MEM supplemented with 10% FCS and 2-mercaptoethanol 
(10
−5 M) at 37°C and 7% CO2. The IL-3–dependent (FDM) cell lines were 
generated by coculturing embryonic day 14.4 fetal liver single-cell suspen-
sions with ﬁ  broblasts expressing a HoxB8 retrovirus in the presence of high 
IL-3 concentrations, as previously described (Ekert et al., 2004). Bak
−/− 
mice were obtained from C. Thompson (Harvard Medical School,   Boston, 
MA), backcrossed for nine generations to ensure a “pure” C57BL/6 ge-
netic background, and intercrossed with Bax
−/− C57BL/6 mice to obtain 
Bax
−/− × Bak
−/− mice (provided by D. Huang, The Walter and Eliza Hall 
Institute, Melbourne, Australia) as described previously (Willis et al., 2005). 
The cell lines were cultured in MEM with Earle’s salts and   L-glutamine. For 
Western blot analysis of isolated mitochondria, antibodies to H
+-ATPase 
(Invitrogen) were used as controls.
GT was puriﬁ  ed  from  Penicillium terlikowskii as described previ-
ously (Waring et al., 1988b). The purity of this preparation was analyzed 
by TLC and HPLC showing the same quality as commercial GT. For apopto-
sis induction, 2 × 10
5 cells/ml MEFs were incubated with the indicated 
concentration of GT or staurosporine (Sigma-Aldrich) for 4 h, and apopto-
sis assays were performed as described in the following paragraphs. 
In some cases, the general caspase inhibitor Ac-ZVAD-fmk (Bachem) or the 
ROS scavengers NAC (Sigma-Aldrich) or MnTBAP (Calbiochem) were 
added as described previously (Pardo et al., 2004). To test the inhibitory 
potency of Ac-ZVAD-fmk, MBL-2–Fas cells were incubated with 1 μg/ml 
α-Fas mAb Jo-2 for 24 h in the presence or absence of 100 μM of the 
  caspase inhibitor, and cell death was analyzed by trypan blue exclusion. 
Nuclei were stained with 10 μg/ml Hoechst 33342 (Invitrogen).
Nuclear, cell membrane, and mitochondrial membrane perturbation
PS exposure and PI uptake was analyzed by FACS or ﬂ  uorescence  mi-
croscopy as described previously (Pardo et al., 2004) using the annexin 
V–FITC kit from BD Biosciences. ∆ψm was measured with the ﬂ  uorescent 
probe 3,3′-dihexyloxacarbocyanine iodide (DiOC6[3]; Invitrogen) and 
ROS generation with 2-hydroxiethidine (2-HE; Invitrogen) as described pre-
viously (Pardo et al., 2004). Nuclear morphology was analyzed by ﬂ  uo-
rescence microscopy with Hoechst 33342. For that, cells were ﬁ  xed with 
Figure 8.  Proposed mechanism for GT-induced cell death and aspergillosis 
treatment. After production by A. fumigatus, GT would enter cells by a re-
dox-dependent mechanism and directly induce a conformational change in 
Bak, leading to mitochondrial depolarization and ROS production. ROS 
production then triggers the mitochondrial release of apoptogenic proteins 
such as cytochrome c (cyt c) and AIF. In this way, both caspase-dependent 
and -independent processes would be launched to induce cell death. By 
blocking either GT or Bak conformational change or even ROS production, 
GT-induced cell death could be prevented and the damage exerted by 
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1% PFA and mounted on a drop of Fluoromount-G (Southern Biotechnology 
Associates, Inc.) containing 10 μg/ml Hoechst 33342, and images were 
taken at room temperature using a microscope (Axioskop 10; Carl Zeiss 
MicroImaging, Inc.), an analysis camera (Axiocam; Carl Zeiss MicroImag-
ing, Inc.), and Vision 3.1.0.0 software (Carl Zeiss MicroImaging, Inc.). 
The objective used was a PlanNeoﬂ  uor (Carl Zeiss MicroImaging, Inc.), 
with a magniﬁ  cation of 40 and a NA of 0.75. Photoshop CS2 (Adobe) 
was used for minor adjustments to contrast and image overlay. In some 
cases, membrane perturbation was also analyzed by ﬂ  uorescence micros-
copy by staining the cells with the annexin V–FITC kit from BD Biosciences. 
Images were taken in the same conditions as described above, but cells 
were mounted on annexin binding buffer (BD Biosciences).
Caspase-3 activation
Cells were ﬁ   xed with 2.5% PFA, incubated with a mAb FITC-labeled 
against the active form of caspase-3 (clone C92605; BD Biosciences), and 
analyzed by FACS as described previously (Pardo et al., 2004).
Cytochrome c release and nuclear translocation of AIF on cells
Cytochrome c release was quantiﬁ   ed by FACS analysis as recently de-
scribed (Waterhouse and Trapani, 2003). In brief, 10
6 MEFs were mildly 
permeabilized with 25 μg/ml digitonin plus 100 mM KCl on ice for 5 min. 
This led to the cellular loss of cytosolic cytochrome c. Cells were washed 
once with cold PBS, ﬁ  xed in 4% PFA, permeabilized with 0.05% saponin 
and 3% BSA, and incubated with the α–cytochrome  c mAb 6H2.B4 
(BD Biosciences) or mouse IgG isotype control (Jackson ImmunoResearch 
Laboratories) followed by α-mouse-FITC secondary antibody (Jackson 
ImmunoResearch Laboratories). The cells were resuspended in 100 μl PFA 
in PBS and analyzed by FACS with a FACScan (BD Biosciences) and Cell-
Quest software (BD Biosciences). For the analysis of the nuclear transloca-
tion of AIF, cells were ﬁ  xed, mounted on poly-L-lysine cover slides, stained 
with a rabbit polyclonal α-AIF antibody (Sigma-Aldrich) followed by the 
secondary goat α-rabbit antibody labeled with Alexa 488 as described 
previously (Pardo et al., 2001), and mounted on a drop of Fluoromount-G. 
Afterward, the cells were analyzed by confocal microscopy. Fluorescence 
images were taken at room temperature on a confocal microscope (TCS 
SP2; Leica) using a 40× objective (HCX PL APO CS; Leica), NA 1.25, 
immersion oil, and confocal software (version 2.61; Leica). Photoshop CS2 
was used for minor adjustments to contrast.
Cytochrome c release from isolated mitochondria
8 × 10
7 MEFs or FDMs were centrifuged and washed once in PBS. The cell 
pellets were resuspended in 500 μl MSH buffer (210 mM mannitol, 70 mM 
sucrose, 20 mM Hepes, 1 mM EDTA, pH 7.5, 100 μM PMSF, 400 ng/ml 
pepstatin, 10 μg/ml leupeptin, 10 μg/ml aprotinin, and 5 μg/ml cytocha-
lasin B). The resuspended cell pellet was incubated on ice for 15 min before 
the cells were broken by passaging 25 times through a 23-gauge needle. 
The lysate was centrifuged at 500 g for 5 min to remove cell debris and 
  nuclei. A crude mitochondrial pellet was then obtained by centrifugation at 
10,000 g for 15 min and resuspended in MSH buffer. The isolated mito-
chondria were incubated with different concentrations of GT (10, 20, and 
50 μM) or 40 nM of recombinant tBid (provided by J.C. Martinou, Univer-
sity of Geneva, Geneva, Switzerland) as a positive control at 37°C for 4 h. 
After incubation, the mitochondria were pelleted, and both pellet and 
  supernatant were tested for cytochrome c release by SDS-PAGE.
Conformational change of Bax and Bak
MEFs were ﬁ  xed in 4% PFA, permeabilized with 0.1% saponin in PBS/5% 
FCS, and incubated with 2 μg/ml rabbit polyclonal α-Bak (NT; Upstate 
Biotechnology), 5 μg/ml rabbit polyclonal α-Bax (NT; Upstate Biotechnol-
ogy), or 5 μg/ml rabbit puriﬁ  ed IgG (control). After two washes with 0.1% 
saponin in PBS, the cells were incubated with α-rabbit-FITC antibody in 
0.1% saponin/PBS/5% FCS, washed twice in 0.1% saponin/PBS, resus-
pended in 1% PFA/PBS, and analyzed by FACS with a FACScan and Cell-
Quest software. The amount of Bax and Bak on isolated mitochondria from 
wt, Bak
−/−, Bax
−/−, and Bak
−/− × Bax
−/− FDMs was determined by wash-
ing the centrifuged mitochondria twice in large amounts MSH buffer 
(to eliminate cytosolic contamination) followed by lysing the mitochondria 
in SDS sample buffer and analysis by α-Bax (Bax-NT) and α-Bak (Bak-NT) 
Western blotting on the same gel. As mitochondrial marker and loading 
control, an antibody against the F0F1 ATPase was used.
In vivo invasive aspergillosis model and GT analysis 
on culture supernatants
Female mice (C57BL/6, Bak
−/− [Jackson ImmunoResearch Laboratories; 
C57BL/6.129, six times backcrossed in C57BL/6], or 129/Sv) were 
  immunosuppressed by subcutaneous injection of 3 mg (112 mg/kg) of 
  hydrocortisone (Sigma-Aldrich) diluted in 200 μl of PBS/0.1% Tween 20 
on days −4,  −2, 0, 2, and 4, as described previously (Tang et al., 
1993). On day 0, mice (6 per group) were infected intranasally with 
5 × 10
6 A. fumigatus B5233 conidia in 20 μl of PBS or with PBS alone. 
Disease development was analyzed by morbidity/mortality of the mice 
  after infection. There was no difference in the sensitivity of C57BL/6 or 
129/Sv mice to A. fumigatus infection, and all infected recipients of both 
mouse strains died during the ﬁ  rst week after infection. GT presence on 
A. fumigatus B5233 culture supernatants was analyzed after 48 h by HPLC 
as described previously (Belkacemi et al., 1999).
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